DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Herrera VL, Colby AH, Ruiz-Opazo N, Coleman DG, Grinstaff MW.
Nucleic acid nanomedicines in Phase II/III clinical trials: translation of nucleic acid therapies for reprogramming cells.
Nanomedicine (Lond) 2018;
13 (16) 2083-2098
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.